Collegium Pharmaceutical, Inc. vs Solid Biosciences Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Collegium Pharmaceutical, Inc. and Solid Biosciences Inc. are worth about the same: $715 M and $713 M (market caps of Oct 28, 2026 for Collegium Pharmaceutical, Inc. and Oct 30, 2026 for Solid Biosciences Inc.).
- Collegium Pharmaceutical, Inc. made a net profit of $63 M, while Solid Biosciences Inc. made a net loss of $174 M.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Collegium Pharmaceutical, Inc. COLL · #10,988 in the world | Solid Biosciences Inc. SLDB · #10,997 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | Pharmaceutical |
| Founded | — | 2013 |
| Size | ||
| Market cap | $715 M | $713 M |
| Revenue | $781 M | — |
| Net income | $63 M▲ best | $-174 M |
| Employees | 234 | — |
| Valuation | ||
| P/E ratio | 18.7× | — |
| Price to sales | 0.9× | — |
| Price to book | 2.4× | 4.0× |
| Free cash flow yield | 45.8%▲ best | -22.1% |
| Profitability | ||
| Gross margin | 59.4% | — |
| Operating margin | 23.0% | — |
| Net margin | 8.1% | — |
| Return on equity | 23.7%▲ best | -109.9% |
| Growth | ||
| Revenue growth | 23.6% | — |
| Revenue growth, 3 years a year | 18.9% | — |
| Earnings per share growth | -7.0% | — |
| Cash | ||
| Free cash flow margin | 42.0% | — |
| Shareholder returns | ||
| Shareholder yield | 3.5% | — |
| Altman Z-score zone | distress | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
Questions and answers#
Which is bigger, Collegium Pharmaceutical, Inc. or Solid Biosciences Inc.?
Collegium Pharmaceutical, Inc. and Solid Biosciences Inc. are worth about the same: $715 M and $713 M (market caps of Oct 28, 2026 for Collegium Pharmaceutical, Inc. and Oct 30, 2026 for Solid Biosciences Inc.).
Which makes more money, Collegium Pharmaceutical, Inc. or Solid Biosciences Inc.?
Collegium Pharmaceutical, Inc. made a net profit of $63 M, while Solid Biosciences Inc. made a net loss of $174 M.
More about Collegium Pharmaceutical, Inc.
- Collegium Pharmaceutical, Inc.: company page
- Who owns Collegium Pharmaceutical, Inc.?
- Collegium Pharmaceutical, Inc. market cap history
- Collegium Pharmaceutical, Inc. revenue by year
- How many employees does Collegium Pharmaceutical, Inc. have?
- Is Collegium Pharmaceutical, Inc. cheap or expensive?
- Collegium Pharmaceutical, Inc. against its peers: ranks and percentiles